Last update 06 Dec 2025

VG2062

Overview

Basic Info

Drug Type
Oncolytic virus
Synonyms
Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 Injection, VG2062
Target
IL-12R x IL15R
Action
modulators
Mechanism
IL-12R modulators(Interleukin-12 receptor modulators), Interleukin-15 receptors modulators(Interleukin-15 receptors modulators)
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid NeoplasmSolid tumor
Inactive Indication-
Originator Organization
Virogin Biotech (Shanghai) Ltd.
Active Organization
Shenzhen Funuojian Biotechnology Co., LtdShenzhen Funuojian Biotechnology Co., LtdVirogin Biotech (Shanghai) Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with VG2062
NCT07262164
/ Not yet recruitingPhase 1
An Open-label, Dose-escalation Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Biological Effects of VG2062 in Patients With Advanced Solid Tumors.
100 Clinical Results associated with VG2062
Login to view more data
100 Translational Medicine associated with VG2062
Login to view more data
100 Patents (Medical) associated with VG2062
Login to view more data
100 Deals associated with VG2062
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
China
Virogin Biotech (Shanghai) Ltd.
01 Jan 2026
Solid tumorIND Approval
China
Shenzhen Funuojian Biotechnology Co., LtdShenzhen Funuojian Biotechnology Co., Ltd
06 Nov 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free